Targeting metabolic dysregulation for fibrosis therapy

X Zhao, JYY Kwan, K Yip, PP Liu, FF Liu - Nature reviews Drug …, 2020 - nature.com
Fibrosis is the abnormal deposition of extracellular matrix, which can lead to organ
dysfunction, morbidity, and death. The disease burden caused by fibrosis is substantial, and …

Therapy for fibrotic diseases: nearing the starting line

SL Friedman, D Sheppard, JS Duffield… - Science translational …, 2013 - science.org
Fibrosis, or the accumulation of extracellular matrix molecules that make up scar tissue, is a
common feature of chronic tissue injury. Pulmonary fibrosis, renal fibrosis, and hepatic …

Targeting fibrosis: Mechanisms and clinical trials

M Zhao, L Wang, M Wang, S Zhou, Y Lu… - Signal transduction and …, 2022 - nature.com
Fibrosis is characterized by the excessive extracellular matrix deposition due to
dysregulated wound and connective tissue repair response. Multiple organs can develop …

[HTML][HTML] Drugs and targets in fibrosis

X Li, L Zhu, B Wang, M Yuan, R Zhu - Frontiers in pharmacology, 2017 - frontiersin.org
Fibrosis contributes to the development of many diseases and many target molecules are
involved in fibrosis. Currently, the majority of fibrosis treatment strategies are limited to …

Therapeutic targets in liver fibrosis

JA Fallowfield - American Journal of Physiology …, 2011 - journals.physiology.org
Detailed analysis of the cellular and molecular mechanisms that mediate liver fibrosis has
provided a framework for therapeutic approaches to prevent, slow down, or even reverse …

Fibrosis: from mechanisms to medicines

NC Henderson, F Rieder, TA Wynn - Nature, 2020 - nature.com
Fibrosis can affect any organ and is responsible for up to 45% of all deaths in the
industrialized world. It has long been thought to be relentlessly progressive and irreversible …

Emerging therapeutic targets for the treatment of hepatic fibrosis

P Fagone, K Mangano, A Pesce, TR Portale… - Drug Discovery …, 2016 - Elsevier
Highlights•Liver fibrosis is an important health problem associated to morbility and
mortality.•Extensive data have provided knowledge of the major key cellular and molecular …

Liver fibrosis: Direct antifibrotic agents and targeted therapies

D Schuppan, M Ashfaq-Khan, AT Yang, YO Kim - Matrix Biology, 2018 - Elsevier
Liver fibrosis and in particular cirrhosis are the major causes of morbidity and mortality of
patients with chronic liver disease. Their prevention or reversal have become major …

Evolving therapies for liver fibrosis

D Schuppan, YO Kim - The Journal of clinical investigation, 2013 - Am Soc Clin Investig
Fibrosis is an intrinsic response to chronic injury, maintaining organ integrity when extensive
necrosis or apoptosis occurs. With protracted damage, fibrosis can progress toward …

Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis

J Lambrecht, LA van Grunsven… - Expert opinion on …, 2020 - Taylor & Francis
Introduction Chronic liver disease is due to various causes of persistent liver damage and
will eventually lead to the development of liver fibrosis. If no treatment is initiated, this …